A detailed history of Clear Harbor Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 25,686 shares of BMY stock, worth $1.51 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
25,686
Previous 15,166 69.37%
Holding current value
$1.51 Million
Previous $629,000 111.29%
% of portfolio
0.11%
Previous 0.05%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$39.66 - $51.75 $417,223 - $544,410
10,520 Added 69.37%
25,686 $1.33 Million
Q2 2024

Jul 17, 2024

SELL
$40.25 - $52.99 $9,660 - $12,717
-240 Reduced 1.56%
15,166 $629,000
Q1 2024

May 10, 2024

SELL
$47.98 - $54.4 $135,879 - $154,060
-2,832 Reduced 15.53%
15,406 $835,000
Q4 2023

Jan 18, 2024

BUY
$48.48 - $57.85 $14,398 - $17,181
297 Added 1.66%
18,238 $935,000
Q3 2023

Oct 26, 2023

SELL
$57.89 - $64.73 $122,668 - $137,162
-2,119 Reduced 10.56%
17,941 $1.04 Million
Q2 2023

Jul 21, 2023

SELL
$63.71 - $70.74 $933,415 - $1.04 Million
-14,651 Reduced 42.21%
20,060 $1.28 Million
Q1 2023

May 04, 2023

BUY
$65.71 - $74.53 $483,822 - $548,764
7,363 Added 26.92%
34,711 $2.41 Million
Q4 2022

Jan 20, 2023

BUY
$68.48 - $81.09 $116,963 - $138,501
1,708 Added 6.66%
27,348 $0
Q2 2022

Jul 20, 2022

SELL
$72.62 - $79.98 $1.23 Million - $1.35 Million
-16,931 Reduced 39.77%
25,640 $1.97 Million
Q1 2022

May 10, 2022

SELL
$61.48 - $73.72 $794,321 - $952,462
-12,920 Reduced 23.28%
42,571 $3.11 Million
Q4 2021

Jan 21, 2022

SELL
$53.63 - $62.52 $1.43 Million - $1.66 Million
-26,620 Reduced 32.42%
55,491 $3.46 Million
Q3 2021

Nov 03, 2021

BUY
$59.17 - $69.31 $916,010 - $1.07 Million
15,481 Added 23.23%
82,111 $4.86 Million
Q2 2021

Aug 06, 2021

SELL
$61.91 - $67.42 $543,817 - $592,217
-8,784 Reduced 11.65%
66,630 $4.45 Million
Q1 2021

Apr 14, 2021

BUY
$59.34 - $66.74 $2.48 Million - $2.79 Million
41,823 Added 124.51%
75,414 $4.76 Million
Q4 2020

Feb 04, 2021

BUY
$57.74 - $65.43 $140,885 - $159,649
2,440 Added 7.83%
33,591 $2.08 Million
Q3 2020

Oct 26, 2020

BUY
$57.43 - $63.64 $112,505 - $124,670
1,959 Added 6.71%
31,151 $1.88 Million
Q2 2020

Aug 05, 2020

BUY
$54.82 - $64.09 $300,906 - $351,790
5,489 Added 23.16%
29,192 $1.72 Million
Q1 2020

May 08, 2020

BUY
$46.4 - $67.43 $478,616 - $695,540
10,315 Added 77.05%
23,703 $1.32 Million
Q4 2019

Jan 29, 2020

BUY
$49.21 - $64.19 $29,378 - $38,321
597 Added 4.67%
13,388 $859,000
Q3 2019

Oct 31, 2019

BUY
$42.77 - $50.71 $194,774 - $230,933
4,554 Added 55.29%
12,791 $649,000
Q2 2019

Jul 22, 2019

SELL
$44.62 - $49.34 $62,468 - $69,076
-1,400 Reduced 14.53%
8,237 $374,000
Q1 2019

Apr 19, 2019

BUY
$45.12 - $53.8 $10,332 - $12,320
229 Added 2.43%
9,637 $460,000
Q4 2018

Feb 11, 2019

BUY
$48.76 - $63.23 $73,140 - $94,845
1,500 Added 18.97%
9,408 $489,000
Q1 2018

May 01, 2018

BUY
$59.92 - $68.98 $10,246 - $11,795
171 Added 2.21%
7,908 $500,000
Q4 2017

Jan 23, 2018

BUY
$59.94 - $65.35 $29,970 - $32,674
500 Added 6.91%
7,737 $474,000
Q3 2017

Oct 25, 2017

BUY
$55.23 - $63.74 $399,699 - $461,286
7,237
7,237 $461,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Clear Harbor Asset Management, LLC Portfolio

Follow Clear Harbor Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.